Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Purple Biotech (PPBT) Gains from Investment Securities (2017 - 2025)

Purple Biotech has reported Gains from Investment Securities over the past 6 years, most recently at -$273000.0 for Q4 2022.

  • Quarterly Gains from Investment Securities fell 2200.0% to -$273000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$530000.0 through Dec 2022, down 390.74% year-over-year, with the annual reading at -$2.3 million for FY2023, 311.11% down from the prior year.
  • Gains from Investment Securities was -$273000.0 for Q4 2022 at Purple Biotech, down from -$232000.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $24000.0 in Q2 2021 and troughed at -$8.1 million in Q4 2020.
  • The 5-year median for Gains from Investment Securities is -$165000.0 (2021), against an average of -$1.2 million.
  • Year-over-year, Gains from Investment Securities skyrocketed 100.16% in 2021 and then crashed 2200.0% in 2022.
  • A 5-year view of Gains from Investment Securities shows it stood at -$3.1 million in 2018, then soared by 83.0% to -$522000.0 in 2019, then tumbled by 1442.53% to -$8.1 million in 2020, then surged by 100.16% to $13000.0 in 2021, then crashed by 2200.0% to -$273000.0 in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Gains from Investment Securities are -$273000.0 (Q4 2022), -$232000.0 (Q3 2022), and -$38000.0 (Q2 2022).